Research / UP / Fundamental state Inspectable configuration
State dimensions Filing 0001819516-24-000047 General Corporate
Debt relative to revenue RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.debt_to_revenue
304.33% · OPTIONAL · NOT_ENOUGH_HISTORY
Capex intensity 78th Own-history percentile · N=9
Evidence method Level · gp.fundamentals.capex_revenue_ratio
2.86% · OPTIONAL · VALID
Operating cash generation 90th Own-history percentile · N=10
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
-13.75% · OPTIONAL · VALID
Revenue growth RAW Current state valid · history insufficient
Evidence method Yoy · gp.fundamentals.revenue
-41.42% · CORE · NOT_ENOUGH_HISTORY
Inventory pressure 90th Own-history percentile · N=10
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
10.82% · OPTIONAL · VALID
Gross margin 50th Own-history percentile · N=10
Evidence method Level · gp.fundamentals.gross_margin
2.34% · CORE · VALID
Operating margin 20th Own-history percentile · N=10
Evidence method Level · gp.fundamentals.operating_margin
-40.34% · CORE · VALID
R&D intensity 80th Own-history percentile · N=10
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
5.36% · OPTIONAL · VALID
SBC intensity 90th Own-history percentile · N=10
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
7.27% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 20 states Self-history eligible
Sep 30, 2021 0/7 normalized Level 3 Mar 31, 2022 0/7 normalized Level 3 Jun 30, 2022 0/7 normalized Level 3 Sep 30, 2022 0/8 normalized Level 3 Sep 30, 2022 0/8 normalized Amended as filed Dec 31, 2022 0/8 normalized Level 3 Mar 31, 2023 0/9 normalized Level 3 Jun 30, 2023 0/9 normalized Level 3 Sep 30, 2023 0/9 normalized Level 3 Dec 31, 2023 6/9 normalized Level 3 Mar 31, 2024 7/9 normalized Level 3 Jun 30, 2024 7/9 normalized Level 3 Sep 30, 2024 8/9 normalized Level 3 Dec 31, 2024 9/9 normalized Level 3 Mar 31, 2025 9/9 normalized Level 3 Jun 30, 2025 9/9 normalized Level 3 Sep 30, 2025 9/9 normalized Level 3 Dec 31, 2025 9/9 normalized Level 3 Mar 31, 2026 9/9 normalized Level 3 Jun 30, 2026 9/9 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Decreased
Previous 306.03%
Current 304.33%
Delta -1.70% Capex Intensity Increased
Previous 2.04%
Current 2.86%
Delta 0.82% Cash Generation Increased
Previous -37.44%
Current -13.75%
Delta 23.69% Growth Increased
Previous -43.98%
Current -41.42%
Delta 2.56% Inventory Pressure Increased
Previous 10.43%
Current 10.82%
Delta 0.39% Margin Increased
Previous -0.59%
Current 2.34%
Delta 2.93% Profitability Increased
Previous -41.90%
Current -40.34%
Delta 1.56% R And D Intensity Decreased
Previous 5.62%
Current 5.36%
Delta -0.26% Sbc Intensity Increased
Previous 5.69%
Current 7.27%
Delta 1.58% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.